Another successful Brainstorm trial

A four-year study at Jerusalem’s Hadassah hospital of the stem cell treatment from Israel’s Brainstorm has been shown to inhibit the progression of the fatal neurological disease ALS (Lou Gehrig’s) in 87 percent of 26 patients.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *